erlotinib has been researched along with 2-(6-methoxy-2-naphthalenyl)propanoic acid in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (2-(6-methoxy-2-naphthalenyl)propanoic acid) | Trials (2-(6-methoxy-2-naphthalenyl)propanoic acid) | Recent Studies (post-2010) (2-(6-methoxy-2-naphthalenyl)propanoic acid) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 11 | 0 | 4 |
| Protein | Taxonomy | erlotinib (IC50) | 2-(6-methoxy-2-naphthalenyl)propanoic acid (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.18 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Guan, J; Liao, J; Luo, J; Qin, X; Talley, JJ; Tortorella, MD; Tu, Z; Zhang, Y | 1 |
1 other study(ies) available for erlotinib and 2-(6-methoxy-2-naphthalenyl)propanoic acid
| Article | Year |
|---|---|
Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer Agents.
Topics: | 2015 |